C5orf38, SNHG3, TMEM105, MEG3, and MYCNOS lncRNAs seem to be potential biomarkers describing the immune profile of HNSCC patients in response to radiotherapy. The gene discussed is IRX2-DT; the disease is head and neck squamous cell carcinoma.